Bioplatinum Technologies LLC

Richmond, VA

UEI
NQDKE38C3E54
CAGE
8Q7N7
Primary NAICS
325411 Medicinal and Botanical Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
2021 Stuart Ave, Richmond, VA 23220, USA
Website
bioplatinumtech.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Bioplatinum Technologies LLC's latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Precision medicine for pancreatic cancer. Biomarker-guided drug delivery of platinum to tumors - this project proposes… Grant · R41CA287830 National Cancer Institute $338,828

Quick answers

What is Bioplatinum Technologies LLC's UEI?

Bioplatinum Technologies LLC's Unique Entity ID (UEI) in SAM.gov is NQDKE38C3E54.

What is Bioplatinum Technologies LLC's CAGE code?

Bioplatinum Technologies LLC's CAGE code is 8Q7N7.

What is Bioplatinum Technologies LLC's primary NAICS code?

Bioplatinum Technologies LLC's primary NAICS code is 325411 (Medicinal and Botanical Manufacturing).

Where is Bioplatinum Technologies LLC located?

Bioplatinum Technologies LLC's physical address in SAM.gov is 2021 Stuart Ave, Richmond, VA 23220, USA.

Is Bioplatinum Technologies LLC registered in SAM.gov?

Yes. Bioplatinum Technologies LLC's SAM.gov registration is active through March 19, 2027.

What is Bioplatinum Technologies LLC's most recent federal award?

Bioplatinum Technologies LLC's most recent federal grant award is Precision medicine for pancreatic cancer. Biomarker-guided drug delivery of platinum to tumors - this project proposes… (R41CA287830), from National Cancer Institute, on August 6, 2024.

On GovTribe

See Bioplatinum Technologies LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login